retatrutide ly3437943 glp-1 gip glucagon triple agonist mechanism Retatrutide is not “just another GLP1.” It Glucagon and retatrutide‐induced ANGPTL3/8 secretion

It is designed as a triple agonist that activates GIP, GLP-1, and glucagon receptors

Thus, this promotes the market growth

The Trump administration had proposed a two-step approach to expand coverage of GLP-1s for obesity in Medicare

Utilization Management : Designing efficient prior authorization and care management processes tailored to GLP-1 medications

The company linked to the largest global raid on an illicit weight-loss drug facility is still selling unlicenced drugs to thousands of customers, a Guardian investigation has found

Bimagrumab is a named after the character Bhima, Samson-like strongman from the Hindu epic Mahabharata The BELIEVE study was initiated by Versanis in Jan 2023, which was spun out of Novartis